Chugai Pharmaceutical (TYO:4519) reported a 31% increase in net income to 97.2 billion yen for the three months ended March 31, from 74.4 billion yen a year ago.
The pharmaceutical group's earnings per share rose to 59.08 yen from 45.21 yen a year ago, according to a Thursday bourse filing.
Revenue jumped 22% to 288.5 billion yen from 236.9 billion yen a year earlier.
For the year ending Dec. 31, the company expects core net income to increase 3.2% to 410.0 billion yen or 250.00 yen per share, while revenue is projected to rise 1.7% to 1.19 trillion yen.
The company plans to pay interim and year-end dividends of 125.00 yen per share each, including a special dividend for its 100th anniversary, totaling 250.00 yen per share for the fiscal year.
Price (JPY): $8285.00, Change: $+34, Percent Change: +0.41%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.